Repeated dose (28-day) administration of silver nanoparticles of varied size and coating does not significantly alter the indigenous murine gut microbiome

Nanotoxicology

Volumn 10, Issue 5, 2016, Pages 513-520

  Wilding, Laura A ^a   Bassis, Christine M ^b   Walacavage, Kim ^a   Hashway, Sara ^a   Leroueil, Pascale R ^a   Morishita, Masako ^a   Maynard, Andrew D ^a   Philbert, Martin A ^a   Bergin, Ingrid L ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Antibiotics; in vivo; metastats; microbiome; mothur; mouse; nanomaterials; pyrosequencing; toxicology

Indexed keywords

CEFOPERAZONE; CITRIC ACID; RNA 16S; SILVER NANOPARTICLE; ANTIINFECTIVE AGENT; METAL NANOPARTICLE; POVIDONE; SILVER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE AMPLIFICATION; GENE SEQUENCE; IN VITRO STUDY; INTESTINE FLORA; MALE; MATERIAL COATING; MICROBIAL COMMUNITY; MICROBIAL DIVERSITY; MOUSE; NANOTOXICOLOGY; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; ANIMAL; C57BL MOUSE; CHEMISTRY; DOSE RESPONSE; DRUG EFFECTS; GENETICS; ORAL DRUG ADMINISTRATION; TOXICITY TESTING;

ADMINISTRATION, ORAL; ANIMALS; ANTI-INFECTIVE AGENTS; CITRIC ACID; DOSE-RESPONSE RELATIONSHIP, DRUG; GASTROINTESTINAL MICROBIOME; MALE; METAL NANOPARTICLES; MICE; MICE, INBRED C57BL; PARTICLE SIZE; POVIDONE; RNA, RIBOSOMAL, 16S; SILVER; TOXICITY TESTS;

EID: 84946426488     PISSN: 17435390     EISSN: 17435404     Source Type: Journal    
DOI: 10.3109/17435390.2015.1078854     Document Type: Article

References (56)

1. Ahmadi F, Rahimi F. 2011. The effect of different levels of nano silver and retention of silver in edible tissues of broilers. World Appl Sci J 12: 1-4
2. Ahmadi J. 2009. Application of different levels of silver nanoparticles in food on the performance and some blood parameters of broiler chickens. World Appl Sci J 7: 24-7
3. Anderson MJ. 2001. A new method for non-parametric multivariate analysis of variance. Aust Ecol 26: 32-46
4. Antonopoulos DA, Huse SM, Morrison HG, Schmidt TM, Sogin ML, Young VB. 2009. Reproducible community dynamics of the gastrointestinal microbiota following antibiotic perturbation. Infect Immun 77: 2367-75
5. Atarashi K, Tanoue T, Honda K. 2010. Induction of lamina propria Th17 cells by intestinal commensal bacteria. Vaccine 28: 8036-8
6. Atarashi K, Tanoue T, Shima T, Imaoka A, Kunawahara T, Momose Y, et al. 2011. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 331: 337-41
7. Axson JL, Stark DI, Bondy AL, Capracotta SS, Maynard AD, Philbert MA, et al. Rapid kinetics of size and pH-dependent dissolution and aggregation of silver nanoparticles in simulated gastric fluid. J Phys Chem. [Epub ahead of print]. doi: 10.1021/acs.jpcc.5b03634
8. Bassis CM, Theriot CM, Young VB. 2014. Alteration of the murine gastrointestinal microbiota by tigecycline leads to increased susceptibility to Clostridium difficile infection. Antimicrob Agents Chemother 58: 2767-74
9. Behra R, Sigg L, Clift MJ, Herzog F, Minghetti M, Johnston B, et al. 2013. Bioavailability of silver nanoparticles and ions: from a chemical and biochemical perspective. J R Soc Interface 10: 20130396
10. Bergin IL, Witzmann FA. 2013. Nanoparticle toxicity by the gastrointestinal route: evidence and knowledge gaps. Int J Biomed Nanosci Nanotechnol 3: 163-210
11. Bhol KC, Schechter PJ. 2007. Effects of nanocrystalline silver (NPI 32101) in a rat model of ulcerative colitis. Dig Dis Sci 52: 2732-42
12. Cole JR, Wang Q, Fish JA, Chai B, McGarrell DM, Sun Y, et al. 2014. Ribosomal Database Project: data and tools for high throughput rRNA analysis. Nucl Acids Res 42: D633-42
13. Drake PL, Hazelwood KJ. 2005. Exposure-related health effects of silver and silver compounds: a review. Ann Occup Hyg 49: 575-85
14. Echegoyen Y, Nerin C. 2013. Nanoparticle release from nano-silver antimicrobial food containers. Food Chem Toxicol 62: 16-22
15. El-Ansary A, Al-Daihan S. 2009. On the toxicity of therapeutically used nanoparticles: an overview. J Toxicol 2009: 754810
16. Fondevila M, Herrer R, Casallas MC, Abecia L, Ducha JJ. 2009. SIlver nanoparticles as a potential antimicrobial additive for weaned pigs. Anim Feed Sci Technol 150: 259-69
17. Hadrup N, Loeschner K, Bergstrom A, Wilcks A, Gao X, Vogel U, et al. 2012. Subacute oral toxicity investigation of nanoparticulate and ionic silver in rats. Arch Toxicol 86: 543-51
18. Hashway SA, Bergin IL, Bassis CM, Uchihashi M, Schmidt K, Young V, et al. 2014. Impact of a hormone-releasing intrauterine system on the vaginal microbiome: a prospective baboon model. J Med Primatol 43: 89-99
19. Hayashi H, Sakamoto M, Benno Y. 2002. Phylogenetic analysis of the human gut microbiota using 16S rDNA clone libraries and strictly anaerobic culture-based methods. Microbiol Immunol 46: 535-48
20. Ivask A, Elbadawy A, Kaweeteerawat C, Boren D, Fischer H, Ji Z, et al. 2014. Toxicity mechanisms in Escherichia coli vary for silver nanoparticles and differ from ionic silver. ACS Nano 8: 374-86
21. Jiang JK, Oberdorster G, Biswas P. 2009. Characterization of size, surface charge, and agglomeration state of nanoparticle dispersions for toxicological studies. J Nanopart Res 11: 77-89
22. Kim JS, Kuk E, Yu KN, Kim JH, Park SJ, Lee HJ, et al. 2007. Antimicrobial effects of silver nanoparticles. Nanomedicine 3: 95-101
23. Krych L, Hansen CH, Hansen AK, van den Berg FW, Nielsen DS. 2013. Quantitatively different, yet qualitatively alike: a meta-analysis of the mouse core gut microbiome with a view towards the human gut microbiome. PLoS One 8: e62578
24. Li X, Lenhart JJ, Walker HW. 2010. Dissolution-accompanied aggregation kinetics of silver nanoparticles. Langmuir 26: 16690-8
25. Loh JV, Percival SL, Woods EJ, Williams NJ, Cochrane CA. 2009. SIlver resistance in MRSA isolated from wound and nasal sources in humans and animals. Int Wound J 6: 32-8
26. Maneewattanapinyo P, Banlunara W, Thammacharoen C, Ekgasit S, Kaewamatawong T. 2011. An evaluation of acute toxicity of colloidal silver nanoparticles. J Vet Med Sci 73: 1417-23
27. McConnell EL, Basit AW, Murdan S. 2008. Measurements of rat and mouse gastrointestinal pH, fluid, and lymphoid tissue, and implications for in vivo experiments. J Pharm Pharmacol 60: 63-70
28. McQuillan JS, Infante HG, Stokes E, Shaw AM. 2012. Silver nanoparticle enhanced silver ion stress response in Escherichia coli K12. Nanotoxicology 6: 857-66
29. McQuillan JS, Shaw AM. 2014. Differential gene regulation in the Ag nanoparticle and Ag(+)-induced silver stress response in Escherichia coli: a full transcriptomic profile. Nanotoxicology 8: 177-84
30. Monopoli MP, Walczyk D, Campbell A, Elia G, Lynch I, Bombelli FB, Dawson KA. 2011. Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. J Am Chem Soc 133: 2525-34
31. Morones-Ramirez J, Winkler J, Spina C, Collins J. 2013. Silver enhances antibiotic activity against gram-negative bacteria. Sci Transl Med 5: 190ra81
32. Morrill K, May K, Leek D, Langland N, Jeane LD, Ventura J, et al. 2013. Spectrum of antimicrobial activity associated with ionic colloidal silver. J Altern Complement Med 19: 224-31
33. Mwilu SK, El Badawy AM, Bradham K, Nelson C, Thomas D, Scheckel KG, et al. 2013. Changes in silver nanoparticles exposed to human synthetic stomach fluid: effects of particle size and surface chemistry. Sci Total Environ 447: 90-8
34. Park K, Park EJ, Chun IK, Choi K, Lee SH, Yoon J, Lee BC. 2011. Bioavailability and toxicokinetics of citrate-coated silver nanoparticles in rats. Arch Pharm Res 34: 153-8
35. Percival SL, Bowler PG, Russel D. 2005. Bacterial resistance to silver in wound care. J Hosp Infect 60: 1-7
36. Pineda L, Chwalibog A, Sawosz E, Lauridsen C, Engberg R, Elnif J, et al. 2012. Effect of silver nanoparticles on growth performance, metabolism and microbial profile of broiler chickens. Arch Anim Nutr 66: 416-29
37. Schloss PD. 2009. Schloss-SOP. Available at: http://www.mothur.org/wiki/[last accessed 30 June 2014]
38. Schloss PD. 2010. The effects of alignment quality, distance calculation method, sequence filtering, and region on the analysis of 16S rRNA gene-based studies. PLoS Comput Biol 6: e1000844
39. Schloss PD, Gevers D, Westcott SL. 2011. Reducing the effects of PCR amplification and sequencing artifacts on 16S rRNA-based studies. PLoS One 6: e27310
40. Schloss PD, Schubert AM, Zackular JP, Iverson KD. 2012. Stabilization of the murine gut microbiome following weaning. Gut Microbes 3: 383-93
41. Shaw BJ, Handy RD. 2011. Physiological effects of nanoparticles on fish: a comparison of nanometals versus metal ions. Environ Int 37: 1083-97
42. Sondi I, Salopek-Sondi B. 2004. Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gram-negative bacteria. J Colloid Interface Sci 275: 177-82
43. Theriot CM, Koenigsknecht MJ, Carlson PE Jr, Hatton GE, Nelson AM, et al. 2014. Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection. Nat Commun 5: 3114
44. Theriot CM, Koumpouras CC, Carlson PE, Bergin II, Aronoff DM, Young VB. 2011. Cefoperazone-treated mice as an experimental platform to assess differential virulence of Clostridium difficile strains. Gut Microbes 2: 326-34
45. U.S. Environmental Protection Agency. IRIS record for silver (CASRN 7440-22-4); 1988
46. Varner KE, El-Badawy A, Feldhake D, Venkatapathy R. 2010. State of the Science Literature Review: Everything Nanosilver and More. Washington, DC: US Environmental Protection Agency
47. Volker C, Oetken M, Oehlmann J. 2013. The biological effects and possible modes of action of nanosilver. Rev Environ Contam Toxicol 223: 81-106
48. Walters CR, Pool EJ, Somerset VS. 2014. Ecotoxicity of silver nanomaterials in the aquatic environment: a review of literature and gaps in nano-toxicological research. J Environ Sci Health A Tox Hazard Subst Environ Eng 49: 1588-601
49. Wang X, Ji ZX, Chang CH, Zhang HY, Wang MY, Liao YP, et al. 2014. Use of Coated Silver Nanoparticles to understand the relationship of particle dissolution and bioavailability to cell and lung toxicological potential. Small 10: 385-98
50. White JR, Nagarajan N, Pop M. 2009. Statistical methods for detecting differentially abundant features in clinical metagenomic samples. PLoS Comput Biol 5: e1000352
51. Wikoff WR, Anfora AT, Liu J, Schultz PG, Lesley SA, Peters EC, Siuzdak G. 2009. Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc Natl Acad Sci USA 106: 3698-703
52. Williams K, Milner J, Boudreau MD, Gokulan K, Cerniglia CE, Khare S. 2015. Effects of subchronic exposure of silver nanoparticles on intestinal microbiota and gut-associated immune responses in the ileum of Sprague-Dawley rats. Nanotoxicology 9: 279-89
53. Young VB. 2012. The intestinal microbiota in health and disease. Curr Opin Gastroenterol 28: 63-9
54. Yue JC, Clayton MK. 2005. A similarity measure based on species proportions. Commun Stat Theory Methods 34: 2123-31
55. Zarei M, Jamnejad A, Khajehali E. 2014. Antibacterial effect of silver nanoparticles against four foodborne pathogens. Jundishapur J Microbiol 7: e8720
56. Zoetendal EG, Collier CT, Koike S, Mackie RI, Gaskins HR. 2004. Molecular ecological analysis of the gastrointestinal microbiota: a review. J Nutr 134: 465-72